Press release
Hereditary Angioedema Market Forecast 2025-2034: Comprehensive Analysis And Growth Opportunities
Hereditary Angioedema
What Is the Projected Growth of the Hereditary Angioedema Market?
In the past few years, the hereditary angioedema market size has exhibited substantial growth. It is projected to expand from $2.62 billion in 2024 to $2.84 billion in 2025, recording a compound annual growth rate (CAGR) of 8.7%. Factors orchestrated in the historical surge include the rising incidence of hereditary angioedema, increased funding in research and development initiatives, a growing tally of approved drugs, enhanced product approval rates, and an upward trend in disposable incomes.
The market for hereditary angioedema is predicted to experience significant expansion in the approaching years. It is forecasted to reach a valuation of $3.93 billion in 2029 with a CAGR of 8.4%. The projected growth during this period can be traced back to factors such as the escalating incidences of rare diseases, amplification in healTH*Care expenditures, growing support from non-profit entities, enhanced understanding of hereditary angioedema and heightened knowledge about early detection. Key trends that are expected to arise in this period include technological progression, the innovation of new treatments, the introduction of novel medicines, sophisticated diagnostic tools, and advancements in the field of genetic testing.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=22002
What Are the Different Hereditary Angioedema Market Segments?
The hereditary angioedema market covered in this report is segmented -
1) By Type: Hereditary Angioedema Type I, Hereditary Angioedema Type II
2) By Treatment Type: Prophylaxis, On-demand
3) By Drug Class: C-1 Esterase Inhibitors, Bradykynin Receptor Antagonist, Kallikrein Inhibitors, Other Drug Classes
4) By Route Of Administration: Subcutaneous, Intravenous, Oral
5) By Distribution channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Hereditary Angioedema Type I: C1-Inhibitor Deficiency, Low C1-Inhibitor Levels, Reduced C1-Inhibitor Function
2) By Hereditary Angioedema Type II: Normal C1-Inhibitor Levels, Dysfunctional C1-Inhibitor, Genetic Mutations In SERPING1 Gene
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=22002&type=smp
What Are the Primary Drivers Shaping the Hereditary Angioedema Market?
The hereditary angioedema market is predicted to expand significantly due to the increasingly prevalent rate of rare diseases. These diseases, also referred to as orphan diseases, impact a minor portion of the population. This heightened rate of rare diseases can be attributed to several factors, including advancements in medical research, shifts in population demographics, and changes in environmental conditions. Hereditary angioedema (HAE) is one such notable rare disease that underscores the urgency for specialized treatments and heightened awareness due to the potential for fatal swelling incidents. Due to its infrequency and genetic features, preemptive diagnosis and specifically designed therapies are crucial for its effective handling and enhanced patient prognosis. As of June 2022, Rare Disease Advisor, a US-based online resource for healTH*Care professionals, estimates that HAE affects roughly 1 out of 50,000 people, with estimations varying from 1 in 10,000 to 1 in 150,000. HAE events in the United States are accountable for about 15,000 to 30,000 ER visits annually. Consequently, the escalating prevalence of rare diseases is bolstering the growth of the hereditary angioedema market.
Which Companies Are Leading in the Hereditary Angioedema Market?
Major companies operating in the hereditary angioedema market are Intellia Therapeutics Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, Otsuka Pharmaceutical Co. Ltd., CSL Limited, Cipla Limited, BioMarin Pharmaceutical Inc., Ionis Pharmaceuticals Inc., BioCryst Pharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., Spark Therapeutics Inc., Pharming Group N.V., Pharvaris N.V., Astria Therapeutics Inc., CENTOGENE N.V., KalVista Pharmaceuticals Inc., ADARx Pharmaceuticals Inc., Adverum Biotechnologies Inc., Attune Pharmaceuticals Inc., Lev Pharmaceuticals Inc.
What Are the Major Trends Shaping the Hereditary Angioedema Market?
Major firms in the hereditary angioedema industry are pioneering creative solutions like oral plasma kallikrein inhibitors, enhancing patient treatment options with greater convenience and effectiveness. These inhibitors work by hampering the function of plasma kallikrein, curbing the overproduction of bradykinin, and are primarily prescribed for hereditary angioedema. For instance, KalVista Pharmaceuticals, Inc., a US-based firm, revealed in September 2024 that the FDA has given its nod to their new drug application (NDA) for the drug sebetralstat. This prospective oral plasma kallikrein inhibitor is designed for on-the-spot treatment of hereditary angioedema (HAE) attacks in both adult and pediatric patients aged 12 or more. By targeting and impeding plasma kallikrein activity, sebetralstat offers a fresh approach to treatment. The FDA's acceptance of the NDA marks a significant step forward towards possible approval and market launch.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/hereditary-angioedema-global-market-report
What Are the Top Revenue-Generating Geographies in the Hereditary Angioedema Market?
North America was the largest region in the hereditary angioedema market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hereditary angioedema market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Hereditary Angioedema Market?
2. What is the CAGR expected in the Hereditary Angioedema Market?
3. What Are the Key Innovations Transforming the Hereditary Angioedema Industry?
4. Which Region Is Leading the Hereditary Angioedema Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hereditary Angioedema Market Forecast 2025-2034: Comprehensive Analysis And Growth Opportunities here
News-ID: 4073534 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Hereditary
Unraveling Hereditary Cancer With The Rising Demand For Hereditary Cancer Testin …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Hereditary Cancer Testing Industry Market Size Be by 2025?
The market encompassing hereditary cancer testing has exhibited robust expansion throughout the recent past, projecting an increase from its value of $4.32 billion in 2024 to reach $4.75 billion for the subsequent year, reflecting a consistent annual…
Leber Hereditary Optic Neuropathy Treatment Market
Introduction
Leber Hereditary Optic Neuropathy (LHON) is a genetic condition that leads to severe vision loss, primarily affecting young adults. This disorder is caused by mutations in mitochondrial DNA, which impairs the function of retinal ganglion cells. As awareness of LHON has grown, so too has the focus on its treatment options. The LHON treatment market is evolving rapidly, driven by advancements in genetic therapies, pharmaceuticals, and supportive care strategies. This…
Hereditary Hemochromatosis Market - Redefining Care, Inspiring Hope: Hereditary …
Newark, New Castle, USA: The "Hereditary Hemochromatosis Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Hereditary Hemochromatosis Market: https://www.growthplusreports.com/report/hereditary-hemochromatosis-market/8793
This latest report researches the industry structure, sales, revenue,…
Hereditary Angioedema Market Research Report 2032
DelveInsight's "Hereditary Angioedema Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the Hereditary Angioedema, historical and forecasted epidemiology as well as the Hereditary Angioedema market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Hereditary Angioedema (HAE) is a rare genetic disorder caused by the deficiency in functional C1 inhibitor (C1INH) that results in recurrent attacks of localized subcutaneous or…
Hereditary Angioedema - Drug Pipeline Landscape, 2022
Global Hereditary Angioedema Market report from Global Insight Services is the single authoritative source of intelligence on hereditary angioedema market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types,…
Hereditary Angioedema - Drug Pipeline Landscape, 2022
Hereditary Angioedema is an infrequent inherited disease that causes substantial swelling in various body tissues, such as the abdomen or face caused by a low level or improper function of a protein called the C1 inhibitor. There are three types of hereditary angioedema namely type I, II, and III.
Hereditary Angioedema is mainly caused by a low level or improper function of a protein called the C1 inhibitor.
Read more about Hereditary…
